1. Home
  2. ACET vs PLCE Comparison

ACET vs PLCE Comparison

Compare ACET & PLCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

HOLD

Current Price

$6.48

Market Cap

69.6M

Sector

Health Care

ML Signal

HOLD

Logo Children's Place Inc. (The)

PLCE

Children's Place Inc. (The)

HOLD

Current Price

$3.36

Market Cap

73.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACET
PLCE
Founded
1947
1969
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Clothing/Shoe/Accessory Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
69.6M
73.8M
IPO Year
2017
1997

Fundamental Metrics

Financial Performance
Metric
ACET
PLCE
Price
$6.48
$3.36
Analyst Decision
Strong Buy
Hold
Analyst Count
3
1
Target Price
$48.33
$4.50
AVG Volume (30 Days)
97.3K
214.9K
Earning Date
05-05-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
63.35
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.45
$2.95
52 Week High
$9.05
$9.56

Technical Indicators

Market Signals
Indicator
ACET
PLCE
Relative Strength Index (RSI) 42.88 40.35
Support Level $6.01 $2.95
Resistance Level $8.34 $3.74
Average True Range (ATR) 0.34 0.20
MACD -0.01 0.02
Stochastic Oscillator 41.87 48.31

Price Performance

Historical Comparison
ACET
PLCE

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

About PLCE Children's Place Inc. (The)

Children's Place Inc operate an omni-channel children's specialty portfolio of brands in North America. It designs, contract to manufacture, and sell fashionable, high-quality apparel, accessories and footwear predominantly at value prices under proprietary The Children's Place, Place, Baby Place, Gymboree, Sugar & Jade, and PJ Place brand names. The Company classifies its business into two segments: The Children's Place U.S. and The Children's Place International.

Share on Social Networks: